HLA expression and tumor-infiltrating immune cells in uveal melanoma

Graefes Arch Clin Exp Ophthalmol. 1996 Jan;234(1):34-42. doi: 10.1007/BF00186516.

Abstract

Background: In uveal melanoma, both the amount of tumor-infiltrating cells and the level of expression of HLA antigens are quite variable. We hypothesized that low levels of HLA expression lead to a lack of antigen presentation, which might prevent proper immunologic recognition of the tumor. This lack of recognition might subsequently lead to low levels of tumor-infiltrating cells.

Methods: To test this hypothesis, we determined the type and number of tumor-infiltrating cells in tumor sections from 24 uveal melanomas. We applied monoclonal antibodies directed against different types of immune cells and compared the results with the expression of HLA class I and class II antigens on the tumor cells.

Results: Infiltrating immune cells were observed in all uveal melanomas (although in small amounts), with a predominance of T lymphocytes. Significant positive correlations were observed between the number of CD3+ cells (T lymphocytes) and monomorphic HLA class I expression, allele-specific HLA-A2 and Bw4 expression, and HLA class II expression. Furthermore, the number of CD4+ cells (T helper cells, monocytes/ macrophages) and of CD11b+ cells (monocytes/macrophages) was significantly correlated with the level of monomorphic HLA class I expression.

Conclusion: These data support our hypothesis that low levels of HLA expression (and therefore a lack of presentation of tumor-specific antigens) may lead to a low level of tumor infiltrate.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal
  • Antigens, CD / immunology
  • Female
  • Histocompatibility Antigens Class I / immunology*
  • Histocompatibility Antigens Class II / immunology*
  • Humans
  • Immunoenzyme Techniques
  • Leukocytes / immunology
  • Lymphocytes, Tumor-Infiltrating / immunology*
  • Male
  • Melanoma / immunology*
  • Middle Aged
  • Uveal Neoplasms / immunology*

Substances

  • Antibodies, Monoclonal
  • Antigens, CD
  • Histocompatibility Antigens Class I
  • Histocompatibility Antigens Class II